SEC Filings

S-1/A
AVEXIS, INC. filed this Form S-1/A on 02/01/2016
Entire Document
 

Table of Contents

receive 12 months of continued base salary and premiums for continued health coverage or, if such termination or resignation occurs within the 12 months following a sale event, as defined in Dr. L'Italien's employment agreement, 18 months.

Mr. Knudten

          Pursuant to his employment agreement, Mr. Knudten is entitled to severance benefits if his employment is terminated without cause or if he resigns for good reason, subject to his execution of a release. If Mr. Knudten is terminated without cause or resigns for good reason, he is eligible to receive 12 months of continued base salary and premiums for continued health coverage or, if such termination or resignation occurs within the 12 months following a sale event, as defined in Mr. Knudten's employment agreement, 18 months.

Dr. Kaspar

          Pursuant to his employment agreement, Dr. Kaspar is entitled to severance benefits if his employment is terminated without cause or if he resigns for good reason, subject to his execution of a release. If Dr. Kaspar is terminated without cause or resigns for good reason, he is eligible to receive 12 months of continued base salary and premiums for continued health coverage.

Equity Benefit Plans

2016 Equity Incentive Plan

          Our board of directors adopted our 2016 Equity Incentive Plan, or 2016 Plan, in January 2016. Our stockholders are expected to approve our 2016 Plan prior to the completion of this offering. No stock award may be granted under the 2016 Plan prior to the date of the underwriting agreement between us and the underwriters managing this offering, pursuant to which our common stock is priced, or the IPO Date. On and after the IPO Date, no additional stock awards will be granted under the 2014 Plan. Our board of directors may amend or suspend the 2016 Plan at any time, although no such action may materially impair the rights under any then-outstanding award without the holder's consent. We will obtain stockholder approval for any amendments to the 2016 Plan as required by law. No incentive stock options may be granted under the 2016 Plan after the tenth anniversary of the effective date of the 2016 Plan.

          Types of Awards.    The 2016 Plan provides for the grant of incentive stock options, nonstatutory stock options, restricted stock awards, restricted stock unit awards, stock appreciation rights, performance stock awards and other forms of equity compensation, or collectively, stock awards. Additionally, the 2016 Plan provides for the grant of performance cash awards. Incentive stock options may be granted only to employees. All other awards may be granted to employees, including officers, non-employee directors, and consultants.

          Share Reserve.    Initially, the aggregate number of shares of our common stock that may be issued pursuant to stock awards under the 2016 Plan is 4,339,451 shares, which is the sum of (1) 2,400,000 new shares, plus (2) the number of shares reserved for issuance under the 2014 Plan on the IPO Date, plus (3) any shares subject to outstanding stock awards that would have otherwise been returned to the 2014 Plan. Additionally, the number of shares of our common stock reserved for issuance under the 2016 Plan will automatically increase on January 1 of each year, beginning on January 1, 2017 (assuming the IPO Date occurs before such date) and continuing through and including January 1, 2026, by 4.0% of the total number of shares of our capital stock outstanding on December 31 of the preceding calendar year, or a lesser number of shares determined by our board of directors. The maximum number of shares that may be issued pursuant to the exercise of incentive stock options under the 2016 Plan is 8,678,902 shares.

158



© AveXis, Inc. All Rights Reserved.